Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study
Participant impression data through 12 months suggest that STS101 was generally perceived as favorable by participants on multiple attributes. Most considered STS101 easy to use and indicated they would be likely to use the product if it were available. Exploratory efficacy evaluations indicated beneficial effects.
Authors
- Robert P. Cowan (ORCID: https://orcid.org/0000-0002-6868-0108)
- Shannon Strom (ORCID: https://orcid.org/0009-0001-2305-0604)
- Larry Charleston (ORCID: https://orcid.org/0000-0002-7708-5394)
- Detlef Albrecht (ORCID: https://orcid.org/0009-0009-8702-8199)
- Jessica Ailani (ORCID: https://orcid.org/0000-0001-8106-4927)
Institutions
- Georgetown University (US)
- Pain and Headache Center (US)
- Hematology Oncology Consultants (US)
- Stanford University (US)
Publication Details
- Journal
- Headache The Journal of Head and Face Pain
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1111/head.15086
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00